Location History:
- Kiryat Uno, IL (2013 - 2017)
- Rehovot, IL (2017 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: Hila Benjamin: Pioneering Innovations in Cancer Diagnosis
Introduction
Hila Benjamin is a distinguished inventor based in Kiryat Uno, Israel, renowned for his significant contributions to the field of cancer diagnosis. With a portfolio of five patents, Benjamin's work focuses on advancing methods for the classification and diagnosis of lung cancer, thereby improving patient outcomes.
Latest Patents
Among Hila Benjamin's latest patents is "Methods for Lung Cancer Classification," which presents specific nucleic acid sequences to aid in the identification, classification, and diagnosis of various lung cancer sub-types. This invention allows for accurate classification based on microRNA expression profiles without the need for further manipulation. Utilizing microRNA microarray data from over two hundred formalin-fixed paraffin-embedded (FFPE) resection samples, fine needle aspiration (FNA) samples, and fine needle biopsy (FNB) samples, this innovative method highlights significant differences in microRNA expression profiles across different lung cancer sub-types.
Another notable patent is titled "Diagnosis and Prognosis of Various Types of Cancers," which provides nucleic acid sequences crucial for the identification, classification, and diagnosis of specific cancers. This technology can also be instrumental in evaluating prognosis based on the expression patterns found in biological samples.
Career Highlights
Hila Benjamin currently works at Rosetta Genomics Ltd., a company dedicated to innovative diagnostic solutions in the oncology field. His work has been instrumental in pioneering new methods that leverage genetic data to enhance cancer diagnosis and treatment options.
Collaborations
Throughout his career, Hila has collaborated with notable colleagues including Nitzan Rosenfeld and Gila Lithwick Yanai, contributing to a dynamic environment of research and innovation aimed at improving cancer care through advanced genetic understanding.
Conclusion
Hila Benjamin stands as a vital figure in the realm of oncology innovations. His inventions not only push the boundaries of medical science but also pave the way for transformative approaches to cancer diagnosis and treatment, ultimately striving to enhance the quality of life for patients diagnosed with lung cancer and other forms of the disease.